Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris
NCT06403501Phase 3Recruiting
- Sponsor
- Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd.
- Start
- May 2024
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of clascoterone in acne vulgaris, sponsored by Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd.. Started May 2024; status: recruiting.
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT06403501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06403501.